BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31351473)

  • 1. Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway.
    Wang N; Wang M
    BMC Anesthesiol; 2019 Jul; 19(1):134. PubMed ID: 31351473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury.
    Shen M; Wang S; Wen X; Han XR; Wang YJ; Zhou XM; Zhang MH; Wu DM; Lu J; Zheng YL
    Biomed Pharmacother; 2017 Nov; 95():885-893. PubMed ID: 28903184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats.
    Li Y; Zeng M; Chen W; Liu C; Wang F; Han X; Zuo Z; Peng S
    PLoS One; 2014; 9(4):e93639. PubMed ID: 24743508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway.
    Wu Y; Wang J; Yu X; Li D; Han X; Fan L
    Cardiol J; 2017; 24(4):409-418. PubMed ID: 28198521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
    Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling.
    Zhang J; Wang C; Yu S; Luo Z; Chen Y; Liu Q; Hua F; Xu G; Yu P
    Sci Rep; 2014 Dec; 4():7317. PubMed ID: 25471136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1β plays a role in the pathogenesis of mesial temporal lobe epilepsy through the PI3K/Akt/mTOR signaling pathway in hippocampal neurons.
    Xiao Z; Peng J; Yang L; Kong H; Yin F
    J Neuroimmunol; 2015 May; 282():110-7. PubMed ID: 25903737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
    Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
    Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sevoflurane postconditioning improves long-term learning and memory of neonatal hypoxia-ischemia brain damage rats via the PI3K/Akt-mPTP pathway.
    Lai Z; Zhang L; Su J; Cai D; Xu Q
    Brain Res; 2016 Jan; 1630():25-37. PubMed ID: 26541582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats.
    Lv J; Wei Y; Chen Y; Zhang X; Gong Z; Jiang Y; Gong Q; Zhou L; Wang H; Xie Y
    Environ Toxicol Pharmacol; 2017 Jun; 52():121-128. PubMed ID: 28411582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the PI3K-AKT-mTOR signaling pathway promotes DEHP-induced Hep3B cell proliferation.
    Chen X; Qin Q; Zhang W; Zhang Y; Zheng H; Liu C; Yang Y; Xiong W; Yuan J
    Food Chem Toxicol; 2013 Sep; 59():325-33. PubMed ID: 23793038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
    Zhang W; Zhang JQ; Meng FM; Xue FS
    J Anesth; 2016 Oct; 30(5):826-33. PubMed ID: 27412350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats.
    Cui Y; Zhang XQ; Cui Y; Xin WJ; Jing J; Liu XG
    Neuroscience; 2010 Nov; 171(1):134-43. PubMed ID: 20826199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
    Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
    Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.
    Chen Z; Yang L; Liu Y; Tang A; Li X; Zhang J; Yang Z
    Mol Cell Biochem; 2014 Jan; 385(1-2):169-77. PubMed ID: 24072614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling.
    Nakao T; Shiota M; Tatemoto Y; Izumi Y; Iwao H
    J Pharmacol Sci; 2007 Dec; 105(4):334-41. PubMed ID: 18057776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β2 induces epithelial-mesenchymal transition in cultured human lens epithelial cells through activation of the PI3K/Akt/mTOR signaling pathway.
    Guo R; Meng Q; Guo H; Xiao L; Yang X; Cui Y; Huang Y
    Mol Med Rep; 2016 Feb; 13(2):1105-10. PubMed ID: 26647778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc enhances intestinal epithelial barrier function through the PI3K/AKT/mTOR signaling pathway in Caco-2 cells.
    Shao Y; Wolf PG; Guo S; Guo Y; Gaskins HR; Zhang B
    J Nutr Biochem; 2017 May; 43():18-26. PubMed ID: 28193579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
    Li Q; Shen L; Wang Z; Jiang HP; Liu LX
    Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.